Tanofovir alafenamide

Tanofovir alafenamide (TAF) is a nucleoside reverse transcriptase inhibitor (NRTI) used in combination with other antiretroviral drugs for the treatment of HIV infection. TAF is a prodrug of the active metabolite tenofovir, which is used in the treatment of hepatitis B virus (HBV). TAF has been shown to be effective in reducing viral load and improving patient outcomes compared to tenofovir disoproxil fumarate (TDF). TAF has also been found to cause fewer kidney and bone-related side effects than TDF.

Tenofovir alafenamide, also sold under the brand name Vemlidy, is an antiviral medication used to fight two viruses: Hepatitis B (HBV) and HIV [1]. Here's a breakdown of its uses and properties:

Treating Hepatitis B:

  • Tenofovir alafenamide is approved for the treatment of chronic hepatitis B infection in adults with compensated liver disease (preserved liver function) [1, 2].
  • It works by inhibiting the Hepatitis B virus's polymerase enzyme, an essential component for viral replication. By blocking this enzyme, tenofovir alafenamide prevents the virus from multiplying in liver cells [2].

Treating HIV (in combination with other medications):

  • Tenofovir alafenamide is part of a combination therapy regimen for treating HIV infection [1].
  • It acts as a nucleotide reverse transcriptase inhibitor (NtRTI). This means it interferes with the HIV virus's ability to convert its genetic material (RNA) into DNA, a crucial step for the virus to replicate and infect new cells [1].

Dosage and Administration:

  • Tenofovir alafenamide comes as a tablet taken orally, usually once daily, with or without food [1].
  • The exact dosage may vary depending on the individual's condition and other medications they are taking. It's crucial to follow your doctor's instructions for proper use.

Important Safety Information:

  • Not a cure: Tenofovir alafenamide does not cure Hepatitis B or HIV infection. It helps control the virus and prevent further complications [1].
  • Potential side effects: Like most medications, tenofovir alafenamide can cause side effects. Some common ones include nausea, headache, fatigue, and diarrhea [1].
  • Drug interactions: Tenofovir alafenamide can interact with other medications. Inform your doctor about all medications you are taking before starting tenofovir alafenamide [1].
  • Monitoring: Regular checkups and monitoring are necessary while using tenofovir alafenamide to track its effectiveness and manage any potential side effects [1].
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AF Nucleoside and nucleotide reverse-transcriptase inhibitors
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
External Links